Skip to main content
SpringerLink
Log in

Calcium Release Channels (Ryanodine Receptors) and Arrhythmogenesis

  • Chapter
Electrical Diseases of the Heart

  • 1699 Accesses

Abstract

Intracellular calcium release channels (ryanodine receptors, RyR) are present on the sarcoplasmic reticulum (SR) in cardiomyocytes and are required for excitation-contraction (EC) coupling in cardiac muscle. Each RyR channel consists of four pore-forming subunits that contain large cytoplasmic domains, which serve as scaffolds for proteins that regulate the activity of the channel. An important regulatory protein is calstabin2 (FKBP12.6), a subunit that stabilizes the closed state of the channel to prevent aberrant calcium (Ca2+) leak from the SR.1 Direct targeting of several protein kinases and phosphatases to the type 2 cardiac RyR channel (RyR2) allows for rapid and localized modulation of SR Ca2+ release in response to extracellular signals.2

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Jayaraman T, Brillantes AM, Timerman AP, et al. FK506 binding protein associated with the calcium release channel (ryanodine receptor). J Biol Chem 1992;267:9474–9477.

    PubMed  CAS  Google Scholar 

  2. Marx SO, Reiken S, Hisamatsu Y, et al. Phosphor-ylation-dependent regulation of ryanodine receptors. A novel role for leucine/isoleucine zippers. J Cell Biol 2001;153(4):699–708.

    Article  PubMed  CAS  Google Scholar 

  3. Tiso N, Stephan DA, Nava A, et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 2001;10(3):189–194.

    Article  PubMed  CAS  Google Scholar 

  4. Priori SG, Napolitano C, Tiso N, et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001;103(2):196–200.

    PubMed  CAS  Google Scholar 

  5. Laitinen PJ, Brown KM, Piippo K, et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 2001;103(4):485–490.

    PubMed  CAS  Google Scholar 

  6. Marx SO, Reiken S, Hisamatsu Y, et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): Defective regulation in failing hearts. Cell 2000;101:365–376.

    Article  PubMed  CAS  Google Scholar 

  7. Yano M, Ono K, Ohkusa T, et al. Altered stoichiometry of FKBP12.6 versus ryanodine receptor as a cause of abnormal Ca2+ leak through ryanodine receptor in heart failure. Circulation 2000;102(17): 2131–2136.

    PubMed  CAS  Google Scholar 

  8. Yano M, Kobayashi S, Kohno M, et al. FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure. Circulation 2003;107(3): 477–484.

    Article  PubMed  CAS  Google Scholar 

  9. Kohno M, Yano M, Kobayashi S, et al. A new cardioprotective agent, JTV519, improves defective channel gating of ryanodine receptor in heart failure. AmJPhysiol Heart Circ Physiol 2003;284(3): H1035–1042.

    CAS  Google Scholar 

  10. Wehrens XH, Lehnart SE, Reiken SR, et al. Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin 2. Science 2004;304(5668):292–296.

    Article  PubMed  CAS  Google Scholar 

  11. Wehrens XH, Lehnart SE, Reiken S, etal. Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure. Proc Natl Acad Sci USA 2005;102(27):9607–9612.

    Article  PubMed  CAS  Google Scholar 

  12. Nabauer M, Callewart G, Cleeman L, Morad M. Regulation of calcium release is gated by calcium current, not gating charge, in cardiac, myocytes. Science 1989;244:800–803.

    Article  PubMed  CAS  Google Scholar 

  13. Bers DM, Guo T. Calcium signaling in cardiac ventricular myocytes. Ann NY Acad Sci 2005;1047: 86–98.

    Article  PubMed  CAS  Google Scholar 

  14. Fabiato A. Time and calcium dependence of activation and inactivation of calcium-induced release of calcium from the sarcoplasmic reticulum of a skinned canine cardiac Purkinje cell. J Gen Physiol 1985;85:247–289.

    Article  PubMed  CAS  Google Scholar 

  15. Wehrens XHT, Lehnart SE, Marks AR. Intracellular calcium release channels and cardiac disease. Annu Rev Physiol 2005;67:69–98.

    Article  PubMed  CAS  Google Scholar 

  16. Cheng H, Lederer WJ, Cannell MB. Calcium sparks: Elementary events underlying excitationcontraction coupling in heart muscle. Science 1993; 262(5134):740–744.

    Article  PubMed  CAS  Google Scholar 

  17. Lindegger N, Niggli E. Paradoxical SR Ca2+ release in guinea-pig cardiac myocytes after β-adrenergic stimulation revealed by two-photon photolysis of caged Ca2+. J Physiol 2005;565(3):801–813.

    Article  PubMed  CAS  Google Scholar 

  18. Cannell MB, Cheng H, Lederer WJ. The control of calcium release in heart muscle. Science 1995; 268(5213):1045–1049.

    Article  PubMed  CAS  Google Scholar 

  19. Marx SO, Gaburjakova J, Gaburjakova M, Henrikson C, Ondrias K, Marks AR. Coupled gating between cardiac calcium release channels (ryanodine receptors). Circ Res 2001;88(11):1151–1158.

    Article  PubMed  CAS  Google Scholar 

  20. Brochet DX, Yang D, Di Maio A, Lederer WJ, Franzini-Armstrong C, Cheng H. Ca2+ blinks: Rapid nanoscopic store calcium signaling. Proc Natl Acad Sci USA 2005;102(8):3099–3104.

    Article  PubMed  CAS  Google Scholar 

  21. Otsu K, Willard HF, Khanna VK, Zorzato F, Green NM, MacLennan DH. Molecular cloning of cDNA encoding the Ca2+ release channel (ryanodine receptor) of rabbit cardiac muscle sarcoplasmic reticulum. J Biol Chem 1990;265:13472–13483.

    PubMed  CAS  Google Scholar 

  22. Tunwell RE, Wickenden C, Bertrand BM, et al. The human cardiac muscle ryanodine receptor-calcium release channel: Identification, primary structure and topological analysis. Biochem J 1996;318:477–487.

    PubMed  CAS  Google Scholar 

  23. Marks AR, Tempst P, Hwang KS, et al. Molecular cloning and characterization of the ryanodine receptor/junctional channel complex cDNA from skeletal muscle sarcoplasmic reticulum. Proc Natl Acad Sci USA 1989;86:8683–8687.

    Article  PubMed  CAS  Google Scholar 

  24. Lam E, Martin MM, Timerman AP, et al. A novel FK506 binding protein can mediate the immuno-suppressive effects of FK506 and is associated with the cardiac ryanodine receptor. J Biol Chem 1995; 270:26511–26522.

    Article  PubMed  CAS  Google Scholar 

  25. Brillantes AB, Ondrias K, Scott A, et al. Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. Cell 1994; 77(4):513–523.

    Article  PubMed  CAS  Google Scholar 

  26. Wehrens XH, Lehnart SE, Huang F, et al. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell 2003;113(7): 829–840.

    Article  PubMed  CAS  Google Scholar 

  27. Lehnart SE, Huang F, Marx SO, Marks AR. Immunophilins and coupled gating of ryanodine receptors. Curr Top Med Chem 2003;3(12):1383–1391.

    Article  PubMed  CAS  Google Scholar 

  28. Chu A, Sumbilla C, Inesi G, Jay SD, Campbell KP. Specific association of calmodulin-dependent protein kinase and related substrates with the junctional sarcoplasmic reticulum of skeletal muscle. Biochemistry 1990;29(25):5899–5905.

    Article  PubMed  CAS  Google Scholar 

  29. Meyers MB, Pickel VM, Sheu SS, Sharma VK, Scotto KW, Fishman GI. Association of sorcin with the cardiac ryanodine receptor. J Biol Chem 1995; 270(44):26411–26418.

    Article  PubMed  CAS  Google Scholar 

  30. Currie S, Loughrey CM, Craig MA, Smith GL. Calcium/calmodulin-dependent protein kinase IIdelta associates with the ryanodine receptor complex and regulates channel function in rabbit heart. Biochem J 2004;377(Pt. 2):357–366.

    Article  PubMed  CAS  Google Scholar 

  31. Wehrens XH, Lehnart SE, Reiken SR, Marks AR. Ca2+/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor. Circ Res 2004;94(6):e61–70.

    Article  PubMed  CAS  Google Scholar 

  32. Zhang L, Kelley J, Schmeisser G, Kobayashi YM, Jones LR. Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane. J Biol Chem 1997;272(37): 23389–23397.

    Article  PubMed  CAS  Google Scholar 

  33. Gyorke I, Hester N, Jones LR, Gyorke S. The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium. Biophys J 2004;86:2121–2128.

    PubMed  Google Scholar 

  34. Terentyev D, Viatchenko-Karpinski S, Gyorke I, Volpe P, Williams SC, Gyorke S. Calsequestrin determines the functional size and stability of cardiac intracellular calcium stores: Mechanism for hereditary arrhythmia. Proc Natl Acad Sci USA 2003;100(20):11759–11764.

    Article  PubMed  CAS  Google Scholar 

  35. Jiang D, Wang R, Xiao B, et al. Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death. Circ Res 2005; 97(11):1173–1181.

    Article  PubMed  CAS  Google Scholar 

  36. Stull LB, Leppo MK, Marban E, Janssen PM. Physiological determinants of contractile force generation and calcium handling in mouse myocardium. J Mol Cell Cardiol 2002;34(10):1367–1376.

    Article  PubMed  CAS  Google Scholar 

  37. Braz JC, Gregory K, Pathak A, et al. PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat Med 2004;10(3):248–254.

    Article  PubMed  CAS  Google Scholar 

  38. Lefkowitz RJ, Rockman HA, Koch WJ. Catecho-lamines, cardiac beta-adrenergic receptors, and heart failure. Circulation 2000;101(14):1634–1637.

    PubMed  CAS  Google Scholar 

  39. Jones LR, Simmerman HK, Wilson WW, Gurd FR, Wegener AD. Purification and characterization of phospholamban from canine cardiac sarcoplasmic reticulum. J Biol Chem 1985;260(12):7721–7730.

    PubMed  CAS  Google Scholar 

  40. Gomez AM, Valdivia HH, Cheng H, et al. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 1997; 276(5313):800–806.

    Article  PubMed  CAS  Google Scholar 

  41. Hain J, Onoue H, Mayrleitner M, Fleischer S, Schindler H. Phosphorylation modulates the function of the calcium release channel of sarcoplasmic reticulum from cardiac muscle. J Biol Chem 1995;270(5): 2074–2081.

    Article  PubMed  CAS  Google Scholar 

  42. Valdivia HH, Kaplan JH, Ellis-Davies GC, Lederer WJ. Rapid adaptation of cardiac ryanodine receptors: Modulation by Mg2+ and phosphorylation. Science 1995;267(5206):1997–2000.

    Article  PubMed  CAS  Google Scholar 

  43. Wehrens XH, Marks AR. Ryanodine Receptors. Structure, Function and Dysfunction in Clinical Disease. New York: Springer, 2004.

    Google Scholar 

  44. Xiao B, Jiang MT, Zhao M, et al. Characterization of a novel PKA phosphorylation site, serine-2030, reveals no PKA hyperphosphorylation of the cardiac ryanodine receptor in canine heart failure. Circ Res 2005;96(8):847–855.

    Article  PubMed  CAS  Google Scholar 

  45. Wehrens XH, Lehnart SE, Reiken S, Vest JA, Wronska A, Marks AR. Ryanodine receptor/ calcium release channel PKA phosphorylation: A critical mediator of heart failure progression. Proc Natl Acad Sci USA 2006;103(3):511–518.

    Article  PubMed  CAS  Google Scholar 

  46. Lokuta AJ, Rogers TB, Lederer WJ, Valdivia HH. Modulation of cardiac ryanodine receptors of swine and rabbit by a phosphorylation-dephosphorylation mechanism. J Phys 1995;487(Pt. 3):609–622.

    CAS  Google Scholar 

  47. Lehnart SE, Wehrens XH, Reiken S, et al. Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias. Cell 2005;123(1):25–35.

    Article  PubMed  CAS  Google Scholar 

  48. d’Amati G, Bagattin A, Bauce B, et al. Juvenile sudden death in a family with polymorphic ventricular arrhythmias caused by a novel RyR2 gene mutation: Evidence of specific morphological substrates. Hum Pathol 2005;36(7):761–767.

    Article  PubMed  CAS  Google Scholar 

  49. Tiziana di Gioia CR, Autore C, Romeo DM, et al. Sudden cardiac death in younger adults: Autopsy diagnosis as a tool for preventive medicine. Hum Pathol 2006;37(7):794–801.

    Article  Google Scholar 

  50. Creighton W, Virmani R, Kutys R, Burke A. Identification of novel missense mutations of cardiac ryanodine receptor gene in exercise-induced sudden death at autopsy. J Mol Diagn 2006;8(1):62–67.

    Article  PubMed  CAS  Google Scholar 

  51. Tester DJ, Kopplin LJ, Will ML, Ackerman MJ. Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing. Heart Rhythm 2005;2(10):1099–1105.

    Article  PubMed  Google Scholar 

  52. Bauce B, Rampazzo A, Basso C, et al. Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: Early diagnosis of asymptomatic carriers. J Am Coll Cardiol 2002; 40(2):341–349.

    Article  PubMed  CAS  Google Scholar 

  53. Tester DJ, Spoon DB, Valdivia HH, Makielski JC, Ackerman MJ. Targeted mutational analysis of the cardiac ryanodine receptor (RyR2) in sudden unexplained death: A molecular autopsy of 51 medical examiner/coroner’s cases. Mayo Clin Proc 2004; 79(11):1380–1384.

    Article  PubMed  CAS  Google Scholar 

  54. Postma AV, Denjoy I, Kamblock J, et al. Catecho-laminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J Med Genet 2005;42(11):863–870.

    Article  PubMed  CAS  Google Scholar 

  55. Priori SG, Napolitano C, Memmi M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002;106(1):69–74.

    Article  PubMed  CAS  Google Scholar 

  56. Laitinen PJ, Swan H, Kontula K. Molecular genetics of exercise-induced polymorphic ventricular tachycardia: Identification of three novel cardiac ryanodine receptor mutations and two common calsequestrin 2 amino-acid polymorphisms. Eur J Hum Genet 2003;11(11):888–891.

    Article  PubMed  CAS  Google Scholar 

  57. Bagattin A, Veronese C, Bauce B, et al. Denaturing HPLC-based approach for detecting RYR2 mutations involved in malignant arrhythmias. Clin Chem 2004;50(7):1148–1155.

    Article  PubMed  CAS  Google Scholar 

  58. Aizawa Y, Ueda K, Komura S, et al. A novel mutation in FKBP12.6 binding region of the human cardiac ryanodine receptor gene (R2401H) in a Japanese patient with catecholaminergic polymorphic ventricular tachycardia. Int J Cardiol 2005; 99(2):343–345.

    Article  PubMed  Google Scholar 

  59. Hasdemir C, Priori SG, Overholt E, Lazzara R. Catecholaminergic polymorphic ventricular tachycardia, recurrent syncope, and implantable loop recorder. J Cardiovasc Electrophysiol 2004;15(6): 729.

    Article  PubMed  Google Scholar 

  60. Allouis M, Probst V, Jaafar P, Schott JJ, Le Marec H. Unusual clinical presentation in a family with catecholaminergic polymorphic ventricular tachycardia due to a G14876A ryanodine receptor gene mutation. Am J Cardiol 2005;95(5):700–702.

    Article  PubMed  CAS  Google Scholar 

  61. Sumitomo N, Harada K, Nagashima M, et al. Catecholaminergic polymorphic ventricular tachycardia: Electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart 2003;89(1):66–70.

    Article  PubMed  CAS  Google Scholar 

  62. Cerrone M, Colombi B, Santoro M, et al. Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor. Circ Res2005;96(10):e77–82.

    Article  CAS  Google Scholar 

  63. Kannankeril P, Mitchell B, Goonasekera S, et al. Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and mild cardiomyopathy. Proc Natl Acad Sci USA 2006;103(32):12179–12184.

    Article  PubMed  CAS  Google Scholar 

  64. Lehnart SE, Wehrens XHT, Laitinen PJ, et al. Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak. Circulation 2004(109): r113–119.

    Google Scholar 

  65. George CH, Jundi H, Walters N, Thomas NL, West RR, Lai FA. Arrhythmogenic mutation-linked defects in ryanodine receptor autoregulation reveal a novel mechanism of Ca2+ release channel dysfunction. Circ Res 2006;98(1):88–97.

    Article  PubMed  CAS  Google Scholar 

  66. George CH, Higgs GV, Lai FA. Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes. Circ Res 2003;93(6): 531–540.

    Article  PubMed  CAS  Google Scholar 

  67. Swan H, Piippo K, Viitasalo M, et al. Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol 1999; 34(7):2035–2042.

    Article  PubMed  CAS  Google Scholar 

  68. Lehnart SE, Terrenoire C, Reiken S, et al. Stabilization of cardiac ryanodine receptor prevents intracellular calcium leak and arrhythmias. Proc Natl Acad Sci USA 2006;103(20):7906–7910.

    Article  PubMed  CAS  Google Scholar 

  69. Jiang D, Xiao B, Yang D, et al. RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR). Proc Natl Acad Sci USA 2004;101(35):13062–13067.

    Article  PubMed  CAS  Google Scholar 

  70. Terentyev D, Nori A, Santoro M, et al. Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death. Circ Res 2006;98(9):1151–1158.

    Article  PubMed  CAS  Google Scholar 

  71. Corrado D, Thiene G. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: Clinical impact of molecular genetic studies. Circulation 2006; 113(13):1634–1637.

    Article  PubMed  Google Scholar 

  72. Priori SG, Napolitano C. Intracellular calcium handling dysfunction and arrhythmogenesis: A new challenge for the electrophysiologist. Circ Res 2005;97(11):1077–1079.

    Article  PubMed  CAS  Google Scholar 

  73. Ma G, Brady WJ, Pollack M, Chan TC. Electrocardiographic manifestations: Digitalis toxicity. J EmergMed 2001;20(2):145–152.

    Article  CAS  Google Scholar 

  74. Scoote M, Williams AJ. The cardiac ryanodine receptor (calcium release channel): Emerging role in heart failure and arrhythmia pathogenesis. Cardiovasc Res 2002;56(3):359–372.

    Article  PubMed  CAS  Google Scholar 

  75. Wehrens XH, Lehnart SE, Marks AR. Ryanodine receptor-targeted anti-arrhythmic therapy. Ann NY Acad Sci 2005;1047:366–375.

    Article  PubMed  CAS  Google Scholar 

  76. Santana LF, Cheng H, Gomez AM, Cannell MB, Lederer WJ. Relation between the sarcolemmal Ca2+ current and Ca2+ sparks and local control theories for cardiac excitation-contraction coupling. Circ Res 1996;78(1):166–171.

    PubMed  CAS  Google Scholar 

  77. Bers DM, Eisner DA, Valdivia HH. Sarcoplasmic reticulum Ca2+ and heart failure: Roles of diastolic leak and Ca2+ transport. Circ Res 2003;93(6):487–490.

    Article  PubMed  CAS  Google Scholar 

  78. Daaka Y, Luttrell LM, Lefkowitz RJ. Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature 1997;390(6655):88–91.

    Article  PubMed  CAS  Google Scholar 

  79. Marks AR. Ryanodine receptors/calcium release channels in heart failure and sudden cardiac death. JMol Cell Cardiol 2001;33(4):615–624.

    Article  CAS  Google Scholar 

  80. Reiken S, Wehrens XH, Vest JA, et al. Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. Circulation 2003;107(19):2459–2466.

    Article  PubMed  CAS  Google Scholar 

  81. De Rosa G, Delogu AB, Piastra M, Chiaretti A, Bloise R, Priori SG. Catecholaminergic polymorphic ventricular tachycardia: Successful emergency treatment with intravenous propranolol. Pediatr Emerg Care 2004;20(3):175–177.

    Article  PubMed  Google Scholar 

  82. Fisher JD, Krikler D, Hallidie-Smith KA. Familial polymorphic ventricular arrhythmias: A quarter century of successful medical treatment based on serial exercise-pharmacologic testing. J Am Coll Cardiol 1999;34(7):2015–2022.

    Article  PubMed  CAS  Google Scholar 

  83. Huang F, Shan J, Reiken S, Wehrens XH, Marks AR. Analysis of calstabin2 (FKBP12.6)-ryanodine receptor interactions: Rescue of heart failure by calstabin2 in mice. Proc Natl Acad Sci USA 2006; 103(9):3456–3461.

    Article  PubMed  CAS  Google Scholar 

  84. Wehrens XH, Marks AR. Novel therapeutic approaches for heart failure by normalising calcium cycling. Nat Rev Drug Discov 2004;3:565–573.

    Article  PubMed  CAS  Google Scholar 

  85. Venetucci LA, Trafford AW, Diaz ME, O’Neill SC, Eisner DA. Reducing ryanodine receptor open probability as a means to abolish spontaneous Ca2+ release and increase Ca2+ transient amplitude in adult ventricular myocytes. Circ Res 2006; 98(10):1299–1305.

    Article  PubMed  CAS  Google Scholar 

  86. Pratt NG. Pathophysiology of heart failure: Neuroendocrine response. Crit Care Nurs Q 1995;18(1): 22–31.

    PubMed  CAS  Google Scholar 

  87. Yano M, Yamamoto T, Ikeda Y, Matsuzaki M. Mechanisms of disease: Ryanodine receptor defects in heart failure and fatal arrhythmia. Nat Clin Pract Cardiovasc Med 2006;3(1):43–52.

    Article  PubMed  CAS  Google Scholar 

  88. Farr MA, Basson CT. Sparking the failing heart. N Engl J Med 2004;351(2):185–187.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX, USA

    Subeena Sood PhD (Postdoctoral Associate)

  2. Department of Molecular Physiology and Biophysics Department of Medicine (in Cardiology), Baylor College of Medicine, Houston, TX, USA

    Xander H.T. Wehrens MD, PhD (Assistant Professor)

Authors
  1. Subeena Sood PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xander H.T. Wehrens MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cardiovascular Boehringer Ingelheim Pharmaceuticals Ridgefield, CT, USA

    Ihor Gussak MD, PhD, FACC (Deputy Therapeutic Area Head, Professor of Pharmacology) (Deputy Therapeutic Area Head, Professor of Pharmacology)

  2. Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Bridgewater, NJ, USA

    Ihor Gussak MD, PhD, FACC (Deputy Therapeutic Area Head, Professor of Pharmacology) (Deputy Therapeutic Area Head, Professor of Pharmacology)

  3. Gordon K. Moe Scholar Masonic Medical Research Laboratory, Utica, NY, USA

    Charles Antzelevitch PhD, FACC, FAHA, FHRS (Executive Director and Director of Research) (Executive Director and Director of Research)

  4. Upstate Medical University, Syracuse, NY, USA

    Charles Antzelevitch PhD, FACC, FAHA, FHRS (Executive Director and Director of Research) (Executive Director and Director of Research)

  5. Heart Failure Research Center Department of Clinical and Experimental Cardiology, Academic Medical Center, Amsterdam, The Netherlands

    Arthur A. M. Wilde MD, PhD, FESC, FAHA (Professor) (Professor)

  6. Mayo Clinic College of Medicine, Rochester, MN, USA

    Paul A. Friedman MD (Professor of Medicine) & Michael J. Ackerman MD, PhD, FACC (Professor of Medicine, Pediatrics and Pharmacology, Consultant Cardiovascular Disease and Pediatric Cardiology, Director Long QT Syndrome Clinic and the Mayo Clinic Windland Smith Rice Sudden Death Genomics) (Professor of Medicine) &  (Professor of Medicine, Pediatrics and Pharmacology, Consultant Cardiovascular Disease and Pediatric Cardiology, Director Long QT Syndrome Clinic and the Mayo Clinic Windland Smith Rice Sudden Death Genomics)

  7. Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN, USA

    Win-Kuang Shen MD (Consultant, Professor of Medicine) (Consultant, Professor of Medicine)

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

Sood, S., Wehrens, X.H. (2008). Calcium Release Channels (Ryanodine Receptors) and Arrhythmogenesis. In: Gussak, I., Antzelevitch, C., Wilde, A.A.M., Friedman, P.A., Ackerman, M.J., Shen, WK. (eds) Electrical Diseases of the Heart. Springer, London. https://doi.org/10.1007/978-1-84628-854-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-854-8_14

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-853-1

  • Online ISBN: 978-1-84628-854-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation